Jazz Pharmaceuticals Buys GW Pharma For $7.2 Billion

CNBC
By Staff of CNBC
Business News Television Channel •

Jazz Pharmaceuticals is buying GW Pharma for $7.2 billion in cash and stock, or $220 per share.

(Video length 00:00:56)

Jazz Pharmaceuticals is buying GW Pharma for $7.2 billion in cash and stock, or $220 per share. CNBC’s Becky Quick reports.

STOCKS IN THIS ARTICLE

JAZZGWPH
Track all markets on TradingView

More from this Author

Target’s Holiday-Quarter Sales And Store Traffic Drop, As Retailer Tries To Snap Its Slump

Target’s Holiday-Quarter Sales And Store Traffic Drop, As Retailer Tries To Snap Its Slump

CNBC •
Comcast Beats Earnings Estimates Despite More Broadband Subscriber Losses

Comcast Beats Earnings Estimates Despite More Broadband Subscriber Losses

CNBC •
GM Raises Guidance After Beating Wall Street Expectations, Lowering Tariff Costs

GM Raises Guidance After Beating Wall Street Expectations, Lowering Tariff Costs

CNBC •

Comments

Back to all articles